| abstract |
Provided is a composition for reducing lung and/or systemic inflammation associated with PM2.5 exposure, comprising docosahexanoic acid, a probiotic strain(such as Bifidobacterium n animalis subsp. Lactis ), Vitamin C and Vitamin E. Also provided is the use of this composition for human subjects living in the environment with the average daily level of PM2.5 between 25 and 500 μg/m 3 , especially between 100 and 500 μg/m 3 . |